PPH vs. XLV
PPH (VanEck Pharmaceutical ETF) and XLV (State Street Health Care Select Sector SPDR ETF) are both Health & Biotech Equities funds - PPH tracks the MVIS US Listed Pharmaceutical 25 Index while XLV tracks the Health Care Select Sector Index. Both are passively managed. Over the past 10 years, PPH returned 8.52%/yr vs 10.01%/yr for XLV. A 0.79 correlation means they provide meaningful diversification when combined. PPH charges 0.36%/yr vs 0.08%/yr for XLV.
Performance
PPH vs. XLV - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PPH achieves a 2.92% return, which is significantly higher than XLV's -0.85% return. Over the past 10 years, PPH has underperformed XLV with an annualized return of 8.52%, while XLV has yielded a comparatively higher 10.01% annualized return.
PPH
- 1D
- 1.79%
- 1M
- 0.31%
- YTD
- 2.92%
- 6M
- 2.77%
- 1Y
- 23.31%
- 3Y*
- 12.54%
- 5Y*
- 9.67%
- 10Y*
- 8.52%
XLV
- 1D
- 1.41%
- 1M
- 1.98%
- YTD
- -0.85%
- 6M
- -0.97%
- 1Y
- 17.16%
- 3Y*
- 6.63%
- 5Y*
- 5.69%
- 10Y*
- 10.01%
PPH vs. XLV - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
PPH VanEck Pharmaceutical ETF | 2.92% | 22.00% | 8.05% | 6.95% | 2.64% | 17.79% | 5.49% | 19.39% | -5.89% | 15.23% |
XLV State Street Health Care Select Sector SPDR ETF | -0.85% | 14.50% | 2.47% | 2.07% | -2.08% | 26.04% | 13.30% | 20.45% | 6.28% | 21.77% |
Correlation
The correlation between PPH and XLV is 0.89, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.89 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.86 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.86 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.85 |
Correlation (All Time) Calculated using the full available price history since Feb 1, 2000 | 0.79 |
The correlation between PPH and XLV has been stable across timeframes, ranging from 0.79 to 0.89 - a consistent structural relationship.
PPH vs. XLV - Sectors Allocation Comparison
Sectors
PPH
XLV
Healthcare
Industrials
-
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
PPH
XLV
Industrials
PPH
XLV
-
Basic Materials
PPH
-
XLV
-
Communication Services
PPH
-
XLV
-
Consumer Cyclical
PPH
-
XLV
-
Consumer Defensive
PPH
-
XLV
-
Energy
PPH
-
XLV
-
Financial Services
PPH
-
XLV
-
Real Estate
PPH
-
XLV
-
Technology
PPH
-
XLV
-
Utilities
PPH
-
XLV
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PPH vs. XLV — Risk / Return Rank
PPH
XLV
PPH vs. XLV - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for VanEck Pharmaceutical ETF (PPH) and State Street Health Care Select Sector SPDR ETF (XLV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| PPH | XLV | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.18 | ||
| Sortino ratioReturn per unit of downside risk | +0.26 | ||
| Omega ratioGain probability vs. loss probability | 1.24 | 1.20 | +0.04 |
| Calmar ratioReturn relative to maximum drawdown | 2.18 | 1.65 | +0.53 |
| Martin ratioReturn relative to average drawdown | 5.30 | 3.89 | +1.41 |
Loading charts...
Drawdowns
PPH vs. XLV - Drawdown Comparison
The maximum PPH drawdown since its inception was -51.45%, which is greater than XLV's maximum drawdown of -39.17%. Use the drawdown chart below to compare losses from any high point for PPH and XLV.
Loading charts...
Drawdown Indicators
| PPH | XLV | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -51.45% | -39.17% | -12.28% |
Max Drawdown (1Y)Largest decline over 1 year | -10.76% | -10.47% | -0.29% |
Max Drawdown (3Y)Largest decline over 3 years | -18.06% | -17.11% | -0.95% |
Max Drawdown (5Y)Largest decline over 5 years | -20.26% | -17.11% | -3.15% |
Max Drawdown (10Y)Largest decline over 10 years | -29.70% | -28.40% | -1.30% |
Current DrawdownCurrent decline from peak | -4.94% | -4.20% | -0.74% |
Average DrawdownAverage peak-to-trough decline | -17.29% | -7.12% | -10.17% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.41% | 4.42% | -0.01% |
Volatility
PPH vs. XLV - Volatility Comparison
VanEck Pharmaceutical ETF (PPH) has a higher volatility of 6.27% compared to State Street Health Care Select Sector SPDR ETF (XLV) at 5.27%. This indicates that PPH's price experiences larger fluctuations and is considered to be riskier than XLV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PPH | XLV | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.27% | 5.27% | +1.00% |
Volatility (6M)Calculated over the trailing 6-month period | 12.27% | 10.68% | +1.59% |
Volatility (1Y)Calculated over the trailing 1-year period | 17.66% | 15.09% | +2.57% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 15.17% | 14.77% | +0.40% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 16.98% | 16.57% | +0.41% |
PPH vs. XLV - Expense Ratio Comparison
PPH has a 0.36% expense ratio, which is higher than XLV's 0.08% expense ratio.
Dividends
PPH vs. XLV - Dividend Comparison
PPH's dividend yield for the trailing twelve months is around 2.05%, more than XLV's 1.66% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PPH VanEck Pharmaceutical ETF | 2.05% | 1.78% | 1.98% | 2.09% | 1.55% | 1.62% | 1.66% | 1.77% | 1.97% | 1.92% | 2.43% | 1.93% |
XLV State Street Health Care Select Sector SPDR ETF | 1.66% | 1.60% | 1.67% | 1.59% | 1.47% | 1.33% | 1.49% | 2.17% | 1.57% | 1.47% | 1.60% | 1.43% |
Frequently Asked Questions
PPH and XLV have a correlation of 0.89, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
PPH has higher volatility (6.27%) compared to XLV (5.27%). In terms of maximum drawdown, PPH dropped -51.45% vs XLV's -39.17%.
On 10-year performance, XLV leads with 10.01% vs 8.52% for PPH. On fees, XLV is cheaper at 0.08% per year. On volatility, XLV has been the lower-risk option at 5.27%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, XLV has performed better with a 10.01% return vs 8.52%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
XLV is cheaper with a 0.08% expense ratio, compared with 0.36% for PPH.
PPH has the higher dividend yield at 2.05%, compared with 1.66% for XLV.
PPH tracks MVIS US Listed Pharmaceutical 25 Index, while XLV tracks Health Care Select Sector Index. They also come from different issuers: VanEck and State Street. Their fees differ too: 0.36% for PPH and 0.08% for XLV.
PPH currently has the higher Sharpe Ratio (1.33 vs 1.14), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for PPH and XLV
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer